Logo
Secure Registration

International Conference on Medicinal Chemistry and Biochemical Analysis

ICMCBA

21st Jul – 22nd Jul 2026 Kathmandu, Nepal

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

1

Select Registration Mode

!
Standard Registration Closed
The deadline for Standard Participation has ended. Participants may continue with Virtual Registration to join the conference remotely.
2

Participant Details

3

Coupon Code

10% OFF on Registration.
Use Coupon Code → EARLY10
4

Terms & Condition

Conference Session Tracks

UN SDG Wheel

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

SDG 3 SDG 4 SDG 9 SDG 15
01 Advancements in Medicinal Chemistry +
This track focuses on the latest breakthroughs in medicinal chemistry, highlighting novel compounds and their therapeutic potentials. Researchers are invited to present their findings on innovative chemical entities and their mechanisms of action.
SDG 3 SDG 4
02 Molecular Modeling and Drug Design +
This session emphasizes the role of molecular modeling techniques in the drug discovery process. Participants will explore computational approaches that enhance the design and optimization of pharmaceutical candidates.
SDG 3 SDG 9
03 Biochemical Analysis Techniques +
This track covers advanced biochemical analysis methods used in the characterization of drug compounds. Presentations will include discussions on analytical techniques that improve the understanding of drug interactions and efficacy.
SDG 3 SDG 9
04 Translational Research in Medicinal Chemistry +
This session highlights the importance of translational research in bridging laboratory discoveries with clinical applications. Researchers will share insights on how medicinal chemistry can inform and enhance patient care.
SDG 3 SDG 4
05 Innovations in Pharmacology +
This track explores cutting-edge developments in pharmacology that impact drug development and therapeutic strategies. Topics will include pharmacokinetics, pharmacodynamics, and the role of pharmacogenomics in personalized medicine.
SDG 3 SDG 9
06 Chemical Synthesis and Drug Development +
This session focuses on innovative chemical synthesis methodologies that facilitate the development of new therapeutic agents. Participants will discuss synthetic strategies that improve yield, purity, and scalability.
SDG 3 SDG 9
07 Therapeutic Innovations in Disease Management +
This track examines novel therapeutic approaches in the management of various diseases through medicinal chemistry. Presentations will highlight case studies and emerging therapies that demonstrate efficacy and safety.
SDG 3 SDG 4
08 Laboratory Techniques in Medicinal Chemistry +
This session showcases essential laboratory techniques that underpin research in medicinal chemistry. Attendees will learn about experimental methodologies that enhance the discovery and development of new drugs.
SDG 3 SDG 4
09 Bimolecular Analysis in Drug Discovery +
This track focuses on the application of biomolecular analysis in the drug discovery process. Researchers will present methodologies that elucidate the interactions between drugs and their biological targets.
SDG 3 SDG 9
10 Natural Products in Medicinal Chemistry +
This session explores the role of natural products as sources of novel drug candidates in medicinal chemistry. Discussions will include extraction, characterization, and the pharmacological evaluation of bioactive compounds.
SDG 3 SDG 15
11 Regulatory Challenges in Drug Development +
This track addresses the regulatory landscape affecting drug development and approval processes. Experts will discuss the implications of regulatory guidelines on the research and commercialization of new therapeutic agents.
SDG 3 SDG 16